Vancouver, British Columbia--(Newsfile Corp. - June 11, 2015) - True Leaf will exhibit its new hemp-based pet products at the Cannabis World Congress in New York at the Jacob K. Javits Convention Center June 17th - 19th.
The company is inviting attendees to visit Booth #137 to learn more about its extension into pet products.
True Leaf is establishing a niche in the North American cannabis industry by focusing on the quality of life for pets with the True Leaf Pet brand.
The company is currently looking for strategic investment partners and $1M - $3M in capital as it launches hemp-based pet treats, CBD supplements and begins the process for a cannabis-based new animal drug application.
"We are excited to come to New York to showcase our latest pet product and to connect with cannabis investors and entrepreneurs like us", says True Leaf Chief Executive Officer Darcy Bomford. "Our experienced and well-rounded team will allow True Leaf to grow into a leading quality of life company."
The Cannabis World Congress will attract top entrepreneurs, business professionals and lawmakers in the cannabis sector. More than 150 exhibitors and 50 speakers are expected. The show will include several investment seminars including the following:
- Why a Wall Street Model is Needed in the Cannabis Industry
How to Use "Crowd-Funding" to Raise Capital For Your Cannabis Business
How to Maximize the Valuation of Your Cannabis Business — For Sale or Investment
How to Attract Wall Street to Your Cannabis Business
If you are interested in attending the CWCB Expo as True Leaf's guest you can receive a discount of $250 off the standard price by registering with the promo code EX152 at www.cwcbexpo.com/new-york-show.
About True Leaf International Ltd:
True Leaf Medicine International Ltd. has filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a licensed producer with a facility located in the Village of Lumby, BC. The company has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting a 'ready-to-build' approval.
For more information, please see True Leaf's website at www.trueleaf.com
For more information contact:
Media
Paul Sullivan
BreakThrough Communications
O: 604-685-4742
M: 604-603-7358
p.sullivan@breakthroughpr.com
Investor Inquiries
Kevin Bottomley
Director
778-389-9933
kevin@trueleaf.com
Source: Maven Brands Inc.